In this episode, Dennis Walker speaks with citizen scientist, biohacker, and filmmaker Victor Mifsud about his life experiences and how a few MDMA experiences helped him have a temporary remission of his retinitis pigmentosa, a disease which has caused him to be legally blind.
Similar Posts
High Doses, Crystals, and the Dangers of Corporate Takeover with Acacea Lewis
Acacea Lewis shares insights accrued from her extensive experience supporting people doing high dose journey work and integration.
Experts Propose Solutions for Regulatory Challenges in the Psychedelic Field
New paper published in Science proposes expert solutions for regulatory challenges in the psychedelic field.
How to Change Your Mind Review: The Psychedelic Hype Train Keeps Chugging
The Netflix documentary ‘How to Change Your Mind’ is great TV even though it fails to provide balanced coverage of psychedelics
Interview with Ian McDonald, CEO & Director of Bright Minds Biosciences
In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss most of Bright Minds’ major projects, including using new psychedelic medicines to treat chronic pain. This is exciting, since it could not only help people with chronic pain issues such as fibromyalgia, but it could also put a dent in the opioid use crisis by preventing people from being prescribed opioids by their doctors to treat pain.
Interview with Awais Spall, Functional Diagnostic Nutrition Practitioner at Integrative Oasis
In this conversation, we discuss some critical points such as how he managed to heal himself through the use of Ayurveda and functional medicine which led him down the path to working with these interesting modalities, how ancestral healing has the ability to significantly influence an individual’s wellbeing overall, how his practice uses entheogens to cure physical ailments such as Traumatic Brain Injury, and more!
Using Mycelium for a Sustainable Future feat. Kimberly Carlson
Join David in this engaging episode as he converses with Kimberly Carlson, CEO & CFO of Mushrooms Inc., a pioneering company at the forefront of driving sustainable practices through innovative mycelium applications.